Malkan, U. Y., & Haznedaroglu, I. C. (2018). Discontinuation of Imatinib Mesylate could Improve Renal Impairment in Chronic Myeloid Leukemia. Open Med (Wars).
शिकागो स्टाइल उद्धरणMalkan, Umit Y., और Ibrahim C. Haznedaroglu. "Discontinuation of Imatinib Mesylate Could Improve Renal Impairment in Chronic Myeloid Leukemia." Open Med (Wars) 2018.
एमएलए उद्धरणMalkan, Umit Y., और Ibrahim C. Haznedaroglu. "Discontinuation of Imatinib Mesylate Could Improve Renal Impairment in Chronic Myeloid Leukemia." Open Med (Wars) 2018.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.